Holding(s) in Company

RNS Number : 5419U

Dechra Pharmaceuticals PLC

22 December 2011

 



For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Dechra Pharamceuticals Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		FMR LLC
4. Full name of shareholder(s)  (if different from 3.):iv		See attached schedule
5. Date of the transaction and date on which the threshold is crossed or reached: v		21 December 2011
6. Date on which issuer notified:		22 December 2011
7. Threshold(s) that is/are crossed or reached: vi, vii		5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB0009633180

3,169,167

3,169,167

3,355,614

3,355,614

5.04

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,355,614

5.04

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
See attached schedule
Proxy Voting:
10. Name of the proxy holder:		FMR LLC
11. Number of voting rights proxy holder will acquire:		186,447
12. Date on which proxy holder will acquire voting rights:		21 December 2011
13. Additional information:	None
14. Contact name:	Shaheen Hussain
15. Contact telephone number:	[e-mail] / 01737 837149

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	FMR LLC
Contact address (registered office for legal entities)	82 Devonshire Street, Boston, MA, 02109 USA
Phone number & email	01737 837148
Other useful information (at least legal representative for legal persons)	Company Secretary
B: Identity of the notifier, if applicable
Full name	FIL Investments International
Contact address	Kingswood Fields, Millfield Lane, Lower Kingswood, Tadworth, Surrey KT20 6RB
Phone number & email	01737 837148
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Authorised to make this filing under power of attorney
C: Additional information
None

FMR
FMR
Issuer name:	DECHRA PHARMACEUTICALS PLC
Current ownership percentage:	5.04%
Total shares held:	3,355,614
Issued share capital:	66,474,826
	SHARES HELD		NOMINEE		MANAGEMENT COMPANY
FMR LLC is the parent holding company of Fidelity	704,530		BROWN BROTHERS HARRIMAN AND CO		FMRCO
Management & Research Company (FMRCO), investment	1,446,750		CITIBANK NA		FMRCO
manager for US mutual funds, FIL Management Trust	247,100		NORTHERN TRUST CO		FMRCO
Company (FMTC), Pyramis Global Advisors Trust Company	951,734		STATE STREET BANK AND TR CO		FMR
(PGATC), a US state chartered bank which acts as a trustee	5,500		STATE STREET BANK AND TR CO		FMRCO
or investment manager of various pension and trust accounts
Pyramis Global Advisors LLC (PGALLC) and
Pyramis Trust Company (PTC).

 

END

 

 

HOLKMMZZVZMGMZM